How AI is Revolutionizing Global in Drug Discovery | Saurabh Mukherjea x Kumar Mayank
Coffee and Investing with Saurabh Mukherjea
- Published
- April 25, 2026
- Duration
- 17:14
- Summary source
- description
- Last updated
- Oct 25, 2026
Discusses artificial-intelligence, investing.
Summary
Drug development is a high-risk endeavor, typically requiring 12 years and $2 billion to bring a single product to market, with a 90% failure rate. In this episode, Saurabh Mukherjea and Kumar Mayank discuss how Artificial Intelligence is being used to navigate these challenges by solving long-standing biological puzzles and streamlining the preclinical r…
Intelligent Report
Sign in to read teasers, or upgrade to Research Pro to commission intelligent report for this episode. Learn more →
Show notes
Drug development is a high-risk endeavor, typically requiring 12 years and $2 billion to bring a single product to market, with a 90% failure rate. In this episode, Saurabh Mukherjea and Kumar Mayank discuss how Artificial Intelligence is being used to navigate these challenges by solving long-standing biological puzzles and streamlining the preclinical research phase.The Challenge of Protein FoldingFor decades, scientists faced Levinthal's Paradox, which suggests that a protein chain can take m
Themes
- artificial-intelligence
- investing